Outcome of Board Meeting held on 25th May, 2026
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.5 pts less than Nifty Microcap 250 and 5.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chemplast Sanmar reported FY2026 annual results with revenue declining 9.1% YoY to Rs 2,170 Cr in standalone operations (consolidated: Rs 4,224 Cr). The company recorded a massive Rs 898 Cr exceptional impairment on its wholly-owned subsidiary CCVL (Cuddalore Vinyls) engaged in Suspension PVC, citing regulatory changes (dropping of anti-dumping duty, removal of customs duty), sharp S-PVC price reductions due to cheap imports, and raw material volatility from West-Asia crisis. Standalone net loss of Rs 883 Cr reflects the impairment impact, while consolidated PAT stood at Rs 145.38 Cr. Auditors BSR & Co. LLP issued an unmodified opinion. No dividend was declared for FY2025-26. Board appointed Mr V S Radhakrishnan (former SBI Deputy MD) as Non-Executive Director and constituted a 3-member Independent Directors committee to evaluate strategic priorities, potential M&A and reorganization opportunities.
The Rs 898 Cr impairment signals severe stress in the PVC commodity business and will significantly impact standalone book value. The strategic committee formation suggests the board is actively considering portfolio restructuring or divestment options for underperforming segments. While specialty chemicals remain profitable, the commodity division's negative capital employed of Rs 1,781 Cr raises concerns about its going concern.